Articles

  • 4 days ago | science.org | Jon Cohen |Meredith Wadman

    Documents released late last week are providing new details about the breadth and depth of the spending cuts the White House is asking Congress to make to public health and biomedical research programs in the 2026 fiscal year that begins on 1 October. Among other things, the plans call for deeper spending and staff cuts at the Centers for Disease Control and Prevention (CDC) than were outlined in a less detailed “skinny budget” that President Donald Trump’s administration released last month.

  • 2 weeks ago | science.org | Jon Cohen

    SAN DIEGO—What do Javan rhinos, Maui parrotbills, and coral trees have in common with Bacillus coahuilensis, a bacterium isolated from the salt-rich lagoons in Cuatro Ciénegas valley in Mexico? All are endangered species, but the disappearance of microbes like B. coahuilensis has not caught much attention outside of microbiology circles. A multidisciplinary group of scientists and conservationists that met here at the Scripps Institution of Oceanography this week wants to change that.

  • 3 weeks ago | science.org | Jon Cohen

    When The Wall Street Journal reported on 1 May that President Donald Trump’s administration was shifting $500 million meant for improving COVID-19 vaccines to develop more ambitious “universal” vaccines for multiple strains of flu and coronaviruses, many infectious disease scientists and vaccine developers were puzzled.

  • 1 month ago | science.org | Meredith Wadman |Jon Cohen |Jocelyn Kaiser

    In a blow to many foreign medical researchers who rely on U.S. funding, the National Institutes of Health (NIH) announced yesterday that by the end of September, it will halt what are known as “foreign subawards,” in which U.S. researchers share their grant money with overseas collaborators.

  • 1 month ago | science.org | Jon Cohen

    Jeffery Taubenberger, who gained fame for unearthing samples of the 1918 flu virus, and ultimately sequencing its entire genome, has been named acting director of the National Institute of Allergy and Infectious Diseases (NIAID), Science has learned. Taubenberger, who has been an intramural researcher at NIAID for nearly 19 years, replaces HIV/AIDS researcher Jeanne Marrazzo, whom President Donald Trump’s administration removed from the job on 31 March.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
41K
Tweets
3K
DMs Open
Yes
Jon Cohen
Jon Cohen @sciencecohen
5 Dec 22

Here's the kind of problem you want to have: Uganda's Ebola cases are dwindling thanks to aggressive containment efforts, but success complicates plans for a rapidly organized trial to do first read-world test of vaccines against Sudan ebolavirus. https://t.co/6dKwPvkLCs https://t.co/MEkoszRzFK

Jon Cohen
Jon Cohen @sciencecohen
28 Nov 22

Ask @SetteLab. I'm not aware of any compelling evidence that SARS-CoV-2 depletion of T or B cells has any significant, longterm impact on the immune system's ability to replace them. SRCV2 doesn't target immune cells, and it's not HIV.

Sam Scarpino
Sam Scarpino @svscarpino

@thilogross @manlius84 @DirkBrockmann @sciencecohen and/or @angie_rasmussen might know if there's any evidence for this.

Jon Cohen
Jon Cohen @sciencecohen
25 Nov 22

As story explains, this isn't all-or-nothing phenomenon. “I think of interference as a small push,” says Aubree Gordon....“It depends on population immunity and when that virus last circulated and flu and COVID vaccination rates.” But interference is a real phenomenon.

Enrique
Enrique @HenrikAborym

@Ivriniel @OrangeInvasion @Aaron_Derfel @EricTopol @ScienceMagazine @sciencecohen @CovidEcoles Yep. México City just hosted a 100k pple music fest during 3 consecutive days. And the reports of respiratory symptons are flooding twitter. Here is a coinfection (Influenzavirus + COVID) that emerged from there. https://t.co/CaNM0Ss18q